The Relationship between Urotensin II and its Receptor and the Clinicopathological Parameters of Breast Cancer

Creative Commons License

Balakan O., KALENDER M. E., Suner A., Cengiz B., ÖZTUZCU S., Bayraktar R., ...More

MEDICAL SCIENCE MONITOR, vol.20, pp.1419-1425, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20
  • Publication Date: 2014
  • Doi Number: 10.12659/msm.890459
  • Journal Name: MEDICAL SCIENCE MONITOR
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1419-1425
  • Hacettepe University Affiliated: Yes

Abstract

Background: Urotensin II is a vasoactive polypeptide. It is known that some vasoactive polypeptides are produced and secreted by tumor cells, and act as a paracrine growth stimulant. The aim of this study was to examine the relationship between urotensin II and its receptor's messenger RNA expression in breast cancer.